Extended Letrozole Reduced Recurrence Risk in Postmenopausal Breast Cancer 5 years of the aromatase inhibitor improved disease-free survival vs 2-3 years Sep 17, 2021
As Safety Data on HPV Vaccine Improves, Why Is Parental Hesitancy Going Up? Findings suggest "an urgent need" to combat sentiment, restore confidence, researchers say Sep 17, 2021
Rechallenge With PARP Inhibitor Slows Relapsed Ovarian Cancer Benefits platinum-sensitive disease irrespective of BRCA, homologous repair status, study showed Sep 17, 2021
Some Reassurance on Cancer Risk With RAI Therapy for Hyperthyroidism No overall risk increase in large meta-analysis, but higher risk seen for thyroid cancer Sep 17, 2021
Longer Hydroxyurea Tied to Improved Sickle-Cell Heart Issues Kids on treatment for less than 1 year had a significantly greater prevalence of LV dilation Sep 16, 2021
AI's Help in Colonoscopy Led to Fewer Missed Adenomas U.S. study explores benefit of newer technology in colon cancer screening, surveillance Sep 15, 2021
More Help on the Way for Lung Cancers With Exon 20 Mutations? Early trials of DZD9008 demonstrated responses in over a third of patients Sep 15, 2021
Cancer Vaccine May Boost Anti-EGFR Efficacy in Non-Small Cell Lung Cancer More than 90% disease control rate, hint of improved PFS in pilot trial Sep 14, 2021
Novel ADC Promising in Certain Non-Squamous Lung Cancers Response rate topped 50% in patients with EGFR wild-type tumors and high MET expression Sep 14, 2021
Stanley Tucci's Tongue Cancer The Oscar-nominated actor opens up about his private battle Sep 13, 2021
More Data in Support of Surgery for Malignant Pleural Mesothelioma Six-month improvement in overall survival with surgery plus chemotherapy versus chemo alone Sep 13, 2021
Meta-Analysis Confirms Benefits of Low-Dose CT Screening for Lung Cancer LDCT associated with a 16% relative reduction in mortality versus no screening Sep 13, 2021
Best Way to Recover Urinary Continence After Prostatectomy? Nerve-sparing prostatectomy, not rehab or duloxetine, most important factor Sep 13, 2021
Which Prostate Biopsy Is Best: Transrectal or Transperineal? Advocates for one may face uphill battle, debate at AUA meeting suggests Sep 13, 2021
Immuno-Oncology Combo Active in Recurrent EGFR/ALK Positive NSCLC Responses in 42% of EGFR group, limited activity in ALK-rearranged lung cancer Sep 12, 2021
Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesothelioma Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
Plant-Based Diet Tied to Better Urological Health in Men "Eat more plants for your prostate and your erections Sep 12, 2021
Durable Response with Immunotherapy Combos in NSCLC with Brain Metastases Analysis of CheckMate 9LA data and phase II study from Spain offer hope in advanced disease Sep 12, 2021
Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancer Analysis of ARAMIS trial results also shows QoL benefits with androgen receptor inhibitor Sep 12, 2021
9/11 Responders Face Higher Risk of Multiple Cancers Longer follow-up sheds light on the long-term consequences of exposure to disaster site Sep 10, 2021
Durable Responses With IL-15 Superagonist in Early Bladder Cancer Addition of N-803 led to better responses in BCG-unresponsive disease Sep 10, 2021
Dual Immunotherapy Boosts Survival in Metastatic NSCLC Benefit with durvalumab-tremelimumab may vary by PD-L1 expression, histology Sep 10, 2021
Cancer Patients, COVID-19, and Long-Term Effects Preventing COVID sequelae can minimize disruption of cancer care, European study finds Sep 09, 2021
Study Sheds Light on Physician-Assisted Suicide in Lung Cancer Patients Patients often did not consult with radiation or medical oncologists Sep 09, 2021
Second-Line Combo Fails to Improve Survival in SCLC No OS difference, but lurbinectedin-doxorubicin was less toxic than standard chemotherapy options Sep 09, 2021
Life Expectancy Still Lower for Blood or Marrow Transplant Recipients Although late mortality has decreased over the past 40 years Sep 09, 2021
Cough, Cancer, PTSD: Two Decades of World Trade Center Studies Research has revealed the fallout of response to a crisis Sep 09, 2021
High Response Rate in Non-Small Cell Lung Cancer With RET Inhibitor Responses in 66-80% of patients from China confirm activity of pralsetinib Sep 09, 2021
TROP2 Antibody-Drug Conjugate Shows Promise in Lung Cancer Disease control observed in over two-thirds of patients at selected dose Sep 08, 2021
Another Ivermectin Flop; 'Instant' Lung Cancer Decision Tool; Triple COPD Tx & Death Highlights from the European Respiratory Society virtual meeting Sep 08, 2021
More Evidence Supports CRC Screening at Younger Ages Historical data among adults ages 45 to 50 show ominous trends Sep 08, 2021
Lymphoma in RA: Disease Activity Matters Strongest risk factors were baseline disease activity scores and bone erosions Sep 08, 2021
Minimally Invasive Surgery Shows Benefit in Colon Cancer Patients started adjuvant therapy faster, had shorter hospital stays compared to open resections Sep 07, 2021
No Survival Bump With PARP Inhibitor in Squamous NSCLC Possible benefit in tumors with positive lung cancer-specific gene panel Sep 07, 2021
Negative Trials Close the Book on Once-Promising SCLC Drug Poor tolerability doomed rovalpituzumab tesirine regimens in four clinical trials Sep 07, 2021
Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry Criteria FDA panel weighs in on lower vector doses and role of animal studies Sep 03, 2021
Adding Mycophenolate Mofetil Improves Outcomes in ITP "Somewhat decreased" quality of life, however, British study finds Sep 01, 2021
PSMA PET Plus MRI Better Detects Clinically Significant Prostate Cancers Increase in negative predictive value and improved sensitivity versus MRI alone Sep 01, 2021
FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
Improved Survival With Surgery in Metastatic Breast Cancer Significant benefits in ER+, PR+, HER2+ disease, neoadjuvant vs adjuvant chemotherapy Aug 31, 2021
